Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy

BACKGROUND: Chemotherapy-induced left ventricular dysfunction represents a major clinical problem, which is often only recognised at an advanced stage, when supportive therapy is ineffective. Although an early heart failure treatment could positively influence the health status and clinical outcome,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lódi, Mária, Priksz, Dániel, Fülöp, Gábor Áron, Bódi, Beáta, Gyöngyösi, Alexandra, Nagy, Lilla, Kovács, Árpád, Kertész, Attila Béla, Kocsis, Judit, Édes, István, Csanádi, Zoltán, Czuriga, István, Kisvárday, Zoltán, Juhász, Béla, Lekli, István, Bai, Péter, Tóth, Attila, Papp, Zoltán, Czuriga, Dániel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642576/
https://www.ncbi.nlm.nih.gov/pubmed/31324258
http://dx.doi.org/10.1186/s12967-019-1978-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642576/
https://www.ncbi.nlm.nih.gov/pubmed/31324258
http://dx.doi.org/10.1186/s12967-019-1978-0

Ejemplares similares